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Abstract
Background: A substantial proportion of the psychiatric burden of disease falls on the world's
poorest nations. Despite this, relatively little is known about the quality and content of clinical
research undertaken in these countries, or the relevance of the interventions evaluated and
specifically that of randomised trials.
This project aims to survey the content, quality and accessibility of a sample of trials relevant to
mental health conducted within low and middle-income countries; to compare these with studies
conducted in high-income countries; and to assess their relevance for the needs of low and middle-
income countries.
Methods: An extensive search for all trials, or possible trials, published in 1991, 1995 and 2000
with participants in low and middle-income countries has already been conducted. Studies
evaluating prevention or treatment of a mental health problem within these three years will be
identified and further searches conducted to assess completeness of the initial search. Data on
study quality and characteristics will be extracted from each report. Accessibility will be estimated
based on whether each citation is available on MEDLINE. Trials relevant to schizophrenia will be
compared with a random sample of schizophrenia trials from high-income countries in the same
years. Topics covered by the trials will be compared with the estimated burden of disease.
Conclusion: Trials and systematic reviews of trials are the gold standard of evaluation of care and
increasingly provide the basis for recommendations to clinicians, to providers of care and to policy
makers. Results from this study will present the first assessment of the scope, quality and
accessibility of mental health trials in low and middle-income countries.
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Most of the global burden of mental illness falls to the
poorest nations, where 80% of world's population live
[1]. Major depression is now a leading cause of disability
throughout the world and ranks fourth in the ten leading
causes of the global burden of disease (measured using
'Disability Adjusted Life Years' – DALYS) [2,3].
According to the World Health Organisation (WHO)
"Most low/middle income countries devote less than 1%
of their health expenditure to mental health. Health poli-
cies, legislation, community care facilities and treatments
for mentally ill people are therefore dismally short of
resources" [4]. Most evaluative research is conducted in
high-income countries, and then applied to low and mid-
dle-income countries [5].
The relevance of existing research to the world's poorer
nations is questionable. Only 10% of the total spent on
health research is directed towards the diseases which are
responsible for 90% of the global burden of disease [6].
Health funding is generally provided by higher income
countries whereas much of the global burden of disease is
in the less rich nations. In fact, expenditure on health
research in many low and middle-income countries is
largely unaccounted for [7]. Interventions evaluated in tri-
als conducted in high-income countries tend to be unaf-
fordable or unavailable to those in poorer countries. For
the world to derive maximum benefit from health
research, the balance of research between rich and poor
countries needs to shift radically [8].
In mental health, the number of trials conducted in any
one country seems to be correlated with the wealth of that
nation: Gross Domestic Product (GDP) has been shown
to be more correlated with the number of schizophrenia
trials than with population size, GDP per capita, or
number of telephones/100 people [9]. If this correlation
is extended to other areas of mental health, the number of
mental health trials would be considerably lower in poor
countries than in rich nations. Furthermore, there is evi-
dence that lower income countries are under-represented
in psychiatric literature. In one survey of high impact jour-
nals, 90% of the literature was derived from "Euro-Amer-
ican" societies [10], in addition a search of the ISI Web
Science database showed that lower and middle-income
countries contributed only 6% of the mental health liter-
ature [11]. It is subsequently likely that less mental health
research activity takes place in poorer countries and, in
addition, that reports of these trials are less accessible.
As part of a project to improve access to pragmatic trials in
developing countries [12] randomised trials, or possibly
randomised trials, with participants from low or middle-
income countries published during 1991, 1995 or 2000
have been identified. This protocol is for a survey to
describe in detail the sub-set of these trials relevant to
mental health care and to describe their quality, content,
accessibility and relevance.
The utility of trials is largely dependent upon their rele-
vance, quality and accessibility. How many trials relevant
to mental health that include participants from low and
middle-income countries is unknown. Of the trials rele-
vant to mental health conducted at least in part within
low and middle income countries, little is known about
their relevance to the health needs in those countries. The
quality of these studies, their accessibility both locally and
internationally, and how these vary according to income
or geographical region are also unclear.
This study will survey reports of trials relevant to mental
health with participants from low and middle-income
countries published in 1991, 1995 and 2000 with the aim
of describing their content, quality and trends over time
and how these vary according to income and broad geo-
graphical region. Other objectives are:
• to compare the topics covered with those in the WHO
estimates of burden of disease;
• to ascertain the availability of citations on Medline as an
indicator of accessibility (Medline was chosen as it is
widely used and available freely world wide); and
• for schizophrenia trials, to compare the content, quality
and accessibility with a sample of those from high income
countries published in the same years.
Methods
The search for randomised trials, or possible randomised
trials, relevant to health care, with participants from low
and/or middle income countries and published in the
years 1991, 1995 or 2000 was performed for the main
Practihc project.
According to the World Bank [13] each country is classi-
fied as low-income, middle-income (subdivided into
lower middle or upper middle), or high-income based on
its Gross National Income (GNI) per capita. In low-
income countries the GNI is $745 or less, in lower middle-
income countries it is $746-$2,975, in upper middle-
income countries it is $2, 976- 9, 205, and in high-income
countries it is 9, 206 or more. Each country is reclassified
on a yearly basis.
The sample years 1991, 1995 and 2000 were chosen in
2003. This was to include a 10-year spread at 5-year inter-
vals. This time period ended 3 years prior to the search so
that papers published in those years would have had thePage 2 of 6
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made available full text copies for over 90% of the cita-
tions published in these three years.
In brief, the methods for the Practihc search initially
involved searching the Cochrane Library's CENTRAL data-
base but expanded to other databases likely to include
studies from low and middle-income countries when it
became clear that CENTRAL was not a complete source of
such studies. The strategy was as follows. Records from the
Cochrane Library's CENTRAL database (Issue 3, 2004)
published in 1991, 1995 and 2000 were downloaded into
a bibliographic management package [14]. The ProCite
database was then searched for names of low and middle-
income countries and terms used to identify lower income
countries, such as 'Africa'. The list of countries was
obtained from the World Bank for each of the three years.
Wherever possible, country names were searched for in
relevant languages and using names relevant for that time
period. Further searches used terms for conditions specific
to low and middle-income countries, such as leprosy,
leshmaniasis, malaria, filarial and tuberculosis. This
helped to identify eligible citations not picked up in
searches using country names. The search results were
transferred into an MS Access database [15].
To assess the completeness of CENTRAL for trials con-
ducted in low and middle income countries, additional
searches of a range of bibliographic databases (see Addi-
tional File 1) were conducted. The search for databases
was intended to be as comprehensive as possible. This
involved utilising personal contacts, WHO web links as
well as using the international search engine Google [16]
for the name of the populous country, bibliographic and
medical terms. The search strategies used within these
databases depended on the constraints of the search inter-
face of each particular database. The simple terms "ran-
domised" and "double blind" were searched in all of the
databases, additional terms were added if the database
allowed. Potentially eligible trials found in these data-
bases were checked to exclude duplicate citations. All
records were printed out and manually checked for eligi-
bility. This was done by LD, CEA and MJ. Each trial was
checked individually and with a 10% overlap. Records
that were clearly not a randomised trial according to the
definitions in the Cochrane Handbook [17] were
excluded, as were those that clearly did not have any par-
ticipants from a low or middle-income country. For all
remaining citations, full text copies were sought and con-
verted, where necessary, to PDF files.
Eligibility criteria
For this project, articles in the main Practihc sample will
be considered eligible for the survey of mental health tri-
als if they meet the following criteria:
• As for the main Practihc project, studies must be ran-
domised trials or possible randomised trials published in
1991, 1995 or 2000 with participants from low or middle
income countries as defined by the World Bank. Accord-
ing to the definitions in the Cochrane Handbook ran-
domised trials, quasi randomised trials and controlled
clinical trials which could possibly be randomised will be
included. We will exclude studies with historical controls
and case control studies.
• Participants in the trials must be people who either had
a mental health problem according to the WHO compiled
classification system (ICD-10) for psychiatric and behav-
ioural disorders, or were people identified as being at
increased risk of developing a mental health problem,
which an intervention could potentially prevent.
Search strategy within the Practihc database
The main Practihc sample will be searched using the title,
keyword and abstract within the MS Access database.
Word roots based on Mesh headings within "Mental
Health" will be utilised with extra terms in Spanish, Por-
tuguese and French (see Additional File 2). This is
intended to be comprehensive. Terms will be added from
the ICD-10 and will be used if the yield increases.
All authors of citations identified in this search will be
sought for within MEDLINE, to identify further trials. This
strategy is based on the assumption that the same people
may have been authors for other eligible trials. The pur-
pose is to assess the completeness of the original search
and identify any reports missed. This is thought to be a
more useful strategy than checking reference lists of eligi-
ble articles which are less likely to have come from low or
middle income countries and are less likely to have come
from the sample year.
To assess whether the search for mental health studies
failed to identify eligible studies (false negatives), all cita-
tions with reports in English will be manually inspected
for eligibility.
In addition, all of the reports in Russian, Ukrainian,
Romanian and Spanish will be manually checked for eli-
gibility. Reports in Chinese, Portuguese and Polish for
which data has been extracted for the Practihc project will
be checked for potentially eligible studies using the
extracted data under the items "problems being
addressed" and "outcomes" (see Additional File 4).
Assessment of potentially eligible studies
Studies identified in the search strategy will be manually
inspected for eligibility for entry into this survey. This
inspection will be done by two investigators working
independently in accordance with the criteria stated ear-Page 3 of 6
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remaining disagreements will be discussed with a third
author and any remaining uncertainty will lead to the
inclusion of a study.
For trials with only the abstract or title in English, resolv-
ing discrepancies may require translation of the full text
and this will be carried out if possible. Where not possi-
ble, the trial will be included for further assessment by the
associate researcher at the point of data extraction.
Selection of the trials of people with schizophrenia
These will be identified using information extracted about
the problem being addressed within each study and the
outcomes reported (see below). Eligible trials will be
those in which participants either had schizophrenia
according to (ICD-10), or were people identified as being
at increased risk of developing schizophrenia which an
intervention could potentially prevent.
The register of trials maintained by the Cochrane Schizo-
phrenia Group will also be used to identify trials relevant
to people with schizophrenia conducted in high-income
countries in the same years. This register is intended to be
as comprehensive as possible and therefore should be rep-
resentative.
A sub-sample of the same number of trials from high
income countries as those identified for low and middle
income countries will be randomly selected from the
Cochrane Schizophrenia Group Register for comparison
of additional variables related to quality and content.
Data extraction
For studies in English, data is being extracted for the main
Practihc project by researchers at the Christian Medical
College, Vellore, India who have been trained by and are
under the supervision of PT. Site visits have been con-
ducted by LD to ensure consistency of data extraction, and
assist with quality control. Data extraction for selected
other languages is being conducted in Argentina and the
UK. LD has trained those extracting in Russian, Chinese
and Ukrainian. There is also a manual of procedures for
data extraction and entry used at all sites. Data being
extracted includes information about the authors, meth-
ods, participants, interventions, outcomes, and also fund-
ing sources and ethics approval. Measures related to
quality include randomisation, sequence generation, allo-
cation concealment, blinding of the intervention and
completeness of follow up. Where possible this data is
extracted from the full report. If this is unavailable the
abstract is used. Data extraction forms were developed fol-
lowing piloting within the Practihc group and the
Cochrane Schizophrenia Group (see Additional File 3).
These definitions were operationalised by how the trial
was reported e.g. classification as single or double blind
depends upon how it is explicitly reported in the paper,
rather than on assumptions or extrapolations made by the
data extractor. Problems being addressed were therefore
written as they had been in the report, these can then be
coded into MeSH terms at the data entry stage. However,
some items that were not explicitly mentioned in the arti-
cle such as site could be coded as "hospital" if this must
obviously have been the case eg in a trial of ECT. This data
is being entered into Meerkat.
For the purposes of this study, extra information will also
be extracted from all of the mental health articles identi-
fied (see Additional File 4). This extra information will be:
• age groups according to the WHO classification;
• classification of validity according to concealment of
allocation, graded as adequate concealment, uncertain
and clearly inadequate as described by Juni 2001 [18] and
also, if a prevention trial
• the type of prevention; primary prevention or relapse
prevention
This information will be extracted by RJSS for studies in
English and Spanish and by associate researchers for
reports in other languages with training and supervision
from RJSS. All associate researchers use a manual of pro-
cedures for data extraction.
Data extracted from the trials identified in this study will
be compared with the data that has already been extracted
for the main Practihc project. At least 10% of reports will
be extracted in duplicate for the original Practihc data. If
this has not ready taken place for the Practihc study this
will be undertaken within this mental health project. In
addition, 10% of the extra mental health data will be dou-
ble data extracted by MJ for reports in English or by asso-
ciate researchers for reports in other languages. The degree
of concordance for each of the variables will be calculated
according to predetermined criterion. For each variable a
percentage agreement of above 80% will be accepted. If
the percentage agreement for any variable is below 80%,
possible reasons will be investigated and further data
extracted to ensure quality control. All data will be entered
into a form within Meerkat so that it can be compared
with the data extracted into Meerkat for the main Practihc
study.
Data will also be extracted from the comparison sample of
schizophrenia trials from high-income countries by MJ
(see Additional File 5) with an additional 10% extracted
by RJSS working independently. The degree of concord-
ance for each of the variables will be calculated. Again, aPage 4 of 6
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termined criterion, will be accepted. The same protocol as
explained above will be followed if the percentage agree-
ment is below this. The accessibility of each report will be
estimated by ascertaining whether it is indexed in Pub
med.
Analyses
The following analyses will be conducted (for detailed
dummy tables see Additional File 6):
Studies will be described in terms of type of report, coun-
try of first author, country/ies of recruitment, language of
full report, age of participants, sex of participants, prob-
lems being addressed, main aims, number randomised,
type of intervention, setting of interventions, site of inter-
vention, duration of intervention, follow up duration,
funding source, funding country, ethics approval, con-
sent, concealment of allocation, sequence generation,
blinding, number of participants with outcome data and
types of outcome and accessibility (tables 1–24).
Trends over the 10-year time frame will be described for
numbers of citations and total numbers of participants
randomised in trials. This will be done for all low and
middle income-countries and according to income of
country of recruitment, using the World Bank definition
(low, lower middle, upper middle and high), and broad
geographic region according to the WHO definition (e.g.
Latin America and Caribbean), (figures 1, 2, 3, 4, 5, 6).
Trends over time will also be described for grading of con-
cealment of allocation, types of intervention biological or
psycho/social, and accessibility (figures 7, 8, 9, 10).
Comparison of income groups and geographic regions of
countries of recruitment will occur for grading of conceal-
ment of allocation, accessibility and number randomised
(see dummy tables 25–27).
The association between the following variables will also
be assessed (see dummy tables 28–30):
• accessibility with language of publication and quality;
• quality as indicated by grading of concealment of allo-
cation with accessibility; and
• source of funding with concealment of allocation and
language.
Comparison with studies from high-income countries
The sub sample of studies for trials in schizophrenia will
be compared with the comparison sample of studies from
high-income countries. Comparison of allocation con-
cealment grading, size of study according to number ran-
domised, type of intervention and accessibility will be
carried out (tables 31–34). A simple statistical analysis
will be carried out in order to compare differences in
means and proportions of these variables.
Comparison with the global burden of disease
Global burden of disease estimates are available from the
WHO for 1990 and 2000–2002. According to advice from
the WHO, differences in the estimates between these years
are mainly due to improvements in information gathering
rather than actual changes in need. The most recent infor-
mation is the most accurate. Global burden of disease esti-
mates for mortality and YLD (years lost to disability) are
available for both for economic groups (high, upper mid-
dle, lower middle and low) and broad geographic regions
e.g. Latin America and Caribbean, excluding high-income
countries (see Additional File 7). These estimates are fur-
ther categorised by cause e.g. unipolar depression.
A "research: need" ratio for all mental health related
causes will be calculated. This will be done by dividing the
number of people randomised in trials by the YLD. The
research: need ratio will be calculated for economic
groups and geographic regions and also for each individ-
ual cause, each age group and each gender group (see
dummy table 37). The findings will be compared with
each other in order to investigate which disorders and
populations are the focus of a relatively high or low
research activity.
Discussion
Trials and systematic reviews of trials are the gold standard
of evaluation of care and increasingly provide the basis for
recommendations to clinicians, to providers of care and
to policy makers. Results from this study will present the
first assessment of the scope, quality and accessibility of
mental health trials in low and middle-income countries.
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